Rane Holdings Ltd
₹1475.80
-21 (1.40%)
Fri, 06 Nov 2026, 00:06 pm
Rane Holdings News
Rane Holdings allots shares in ZF LIFETEC JV
Rane Holdings Limited allotted 5,15,954 equity shares in its joint venture, ZF LIFETEC Rane Automotive India Pvt Ltd, via a rights issue. The company maintains its 49% equity holding post-allotment.
30 Oct 2026
companies
Rane Holdings invests ₹80.85 crore in ZF JV
Rane Holdings approves ₹80.85 crore rights issue subscription in ZF LIFETEC Rane Automotive India to fund capex, maintaining 49% stake.
22 Oct 2026
companies
Rane Holdings subsidiary gets GST demand dropped
Rane Steering Systems, a wholly owned subsidiary of Rane Holdings, received an order dropping a ₹10.07 crore GST demand for FY23-24.
09 Oct 2026
companies
Rane Holdings promoter acquires shares via transmission
Meenakshi Ganesh, a promoter of Rane Holdings, acquired 1,348 equity shares through transmission from Late Kripa Subramaniam on September 29, 2026.
05 Oct 2026
companies
Rane Holdings subsidiary gets GST notice
Rane Steering Systems received a show cause notice from GST authorities for ineligible ITC claims in FY23-24, with potential liability of ₹10.07 crore.
25 Sept 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo